全球胃部器材市場：市場規模、佔有率和趨勢分析（2026-2032 年）

全球胃部器材市場報告（至2032年）

2025年，全球胃部器材市場規模超過1.24億美元。預計該市場將以約1.1%的適度年複合成長率成長，到2032年達到約1.34億美元。

這份綜合報告涵蓋了全球胃部器械市場，包括胃內球囊和胃束帶。目前，胃束帶僅佔市場佔有率的一小部分，且其市場佔有率下降。

該分析包括銷售量、平均售價（ASP）、市場規模、成長趨勢、市場促進因素和限制因素、截至2032年的市場預測以及截至2022年的歷史資料。還涵蓋了近期併購、公司簡介、產品系列和主要參與者。

該市場的成長受到減重手術的激烈競爭以及GLP-1受體促效劑快速普及的限制。胃部裝置正日益被定位為暫時性、可逆性或過渡性治療方法，而非肥胖症的根治性治療方法。

市場概覽

全球胃部器械市場包括用於輔助減重介入的器械，主要包括胃內球囊和胃束帶。這些器械目的是透過暫時減少胃容量或改變解剖結構來幫助患者減重。

目前，胃內球囊佔據了更大的市場。它們通常被定位為一種創傷較小、暫時且可逆的選擇，適用於不願接受手術或不適合接受創傷性更大的減肥手術的患者。

胃束帶市場正大幅萎縮。即使是可調節的束帶系統，包括傳統的LAP-BAND® 平台，也因長期併發症發生率高、需要再次手術以及外科醫生轉向其他肥胖治療方法而持續下滑。

自2023年以來，GLP-1受體促效劑對胃部器械市場產生了顯著影響。尤其是在美國，隨著藥物減重療法日益普及，2023年的球囊血管成形術的數量急劇下降。雖然長期依從性和耐受性仍在評估中，但其對介入性減重手術的短期影響是巨大的。

市場促進因素

肥胖率的持續上升支撐著人們對減重干預措施的長期需求。病理性肥胖通常定義為身體品質指數（BMI）超過40，或BMI達到或超過35並伴隨肥胖相關合併症，例如第2型糖尿病或高血壓。不斷成長的患者群體支撐著整個肥胖治療體系。

然而，肥胖症盛行率對胃部裝置的影響並不直接。與減重手術或藥物治療相比，胃內球囊和胃束帶的目標患者群更為有限。最大的需求來自那些尋求非手術、暫時性或可逆性治療方法的患者。

新的發展和市場重新定位也在重塑胃部器械市場。隨著胃束帶和胃球囊手術數量的逐漸減少，製造商重新定位胃部器械，不再將其視為永久性解決方案，而是作為輔助性治療和過渡療法。產品研發越來越注重微創系統，以滿足特定患者的需求，同時減輕手術負擔和解剖結構改變。

市場限制

減重手術仍是胃部裝置市場發展的最大阻礙因素。袖狀切除術和胃旁路移植術等外科手術能夠提供更持久的減重，並有充分的臨床證據支持。因此，對於許多重度肥胖患者而言，外科手術已成為首選的標準治療方案。

機器人輔助減肥手術進一步加速這一趨勢。機器人平台改善了外科醫生在複雜減重手術中的工作環境、視野和精準度。這提升了手術的提案，使其成為在擁有機器人平台的醫院更具吸引力的手術選擇。

GLP-1受體促效劑也是一個主要的阻礙因素。自2023年以來，這些藥物降低了對某些減重干預措施的需求，尤其是在美國，胃內球囊的需求下降。雖然長期依從性、成本和永續性仍在評估中，但它們的短期影響足以對胃內器械市場造成相當大的壓力。

市場覆蓋範圍和資料範圍

• 定量分析：市場規模、市場佔有率、市場預測、市場成長率、銷售量、平均售價。
• 定性研究範圍：市場促進因素和阻礙因素、市場規模和成長趨勢、近期併購、公司概況、產品系列和主要競爭對手。
• 目標時期：基準年為2025年，預測至2032年，歷史資料截至2022年。
• 資料類型包括：銷售量、平均售價、市場規模和成長趨勢、市場促進因素和阻礙因素、到2032年的市場預測、歷史資料、近期併購、公司簡介和產品系列。
• 方法注記：市場收入是根據銷售量和平均售價計算的，並依設備類型進行細分，以評估對胃束帶和胃球囊的需求。

本報告目的是幫助讀者評估肥胖症的流行、GLP-1 藥物的廣泛使用、減肥手術、機器人輔助手術以及產品定位的轉變等因素如何影響全球胃部設備市場。

目標市場及區隔

胃部器材市場

• 裝置類型：胃束帶和胃球囊。

胃束帶包括用於限制胃容量的可調式束帶系統。目前，該細分市場在整個胃部器械市場中佔比小規模，且市場佔有率下降。

胃內球囊是一種臨時性的、佔據胃內空間的裝置，目的是幫助短期減重，通常與生活方式的改變和更廣泛的肥胖管理計劃一起使用。

透過市場規模、市場佔有率、市場預測、市場成長率、銷售量和平均售價等相關定量指標對每個細分市場進行分析。

競爭分析

Allurion Technologies是全球胃內球囊市場的領導者。該公司提供Allurion®球囊系統，這是一種可吞嚥的微創減重解決方案，目的是消除插入和取出過程中對內視鏡的依賴。該平台定位為一種微創且可逆的替代方案，可取代外科減肥手術和傳統內視鏡球囊療法。

2026年2月，Allurion公司獲得美國FDA的胃內球囊系統上市前核准，該系統可用於短期減重，並需配合生活方式的改變。這標誌著該公司正式進軍美國市場，並顯著擴大了企業發展。這項監管里程碑鞏固了Allurion在北美胃部醫療器材領域的地位。

在將Apollo Endosurgery整合到其產品組合後，波士頓科學公司在胃部器械領域保持了顯著的地位。其市場地位得益於腔內和肥胖相關技術，包括OverStitch™內視鏡縫合系統，這些技術與公司更廣泛的微創和胃腸外科業務相輔相成。

2025年，Medtimo（前身為ReShape Lifesciences）仍是一家著重小眾市場的競爭者，主要產品是其傳統的LAP-BAND®可調節胃束帶系統。儘管該公司持續研發其他肥胖治療技術，包括以球囊為基礎的解決方案，但截至2025年，這些產品尚未對市場收入做出實質貢獻。

科技和醫療治療的發展趨勢

胃內球囊正日益成為一種治療肥胖症的暫時性、可逆性選擇。隨著市場逐漸拋棄永久性或改變解剖結構的器械，這種定位尤其重要。

可吞嚥球囊系統是研發的重點領域。目的是減少或避免內視鏡手術的產品可能會吸引那些尋求創傷性較小的治療方法並減輕手術負擔的患者。

隨著臨床趨勢轉向袖狀切除術、胃繞道手術和其他肥胖症治療方法，胃束帶手術的使用率持續下降。長期併發症率高以及再次手術率增加，降低了外科醫生和患者對胃束帶治療的興趣。

GLP-1製劑重塑肥胖症治療模式。它們的快速普及為非手術減重干預措施制定了新的比較標準，也給胃部裝置製造商帶來了壓力，他們需要證明其產品在藥物依從性、成本和適應症等方面都具有挑戰性的患者群體中的價值。

機器人輔助減重手術提升外科治療的吸引力。隨著手術流程變得更加精準和標準化，能夠帶來更持久療效的外科技術給胃部裝置帶來了越來越大的壓力。

製造商正日益將胃部裝置定位為輔助性治療或過渡療法。這可能包括用於那些尚未準備好接受手術、不仿單標示外接受手術或需要在進行更徹底的干涉之前暫時減重的患者。

地區

本報告涵蓋全球調查區域，包括北美、歐洲、亞太地區、拉丁美洲以及中東和非洲。

這份報告的意義

目前全球胃部器材市場規模有多大？預計到2032年將如何成長？

胃內球囊和胃束帶在全球肥胖治療市場取得了什麼樣的成績？

銷售量、平均售價和市場規模如何隨時間變化？

為什麼胃束帶手術的市場佔有率仍然很小並且還在下降？

GLP-1製劑的廣泛使用胃內球囊導管插入術的數量產生了怎樣的影響？

胃部裝置目前在暫時性、可逆性或過渡性治療中扮演怎樣的角色？

減重手術和機器人輔助減重手術是如何阻礙市場成長的？

哪些公司活躍於胃部器材市場？ Allurion Technologies、Boston Scientific 和 Medtimo 在這其中又扮演著怎樣的角色？

iData Research 的《全球胃部器材市場報告》透過詳細的市場規模、平均售價（ASP）趨勢、預測和競爭格局分析，解答了這些問題。本報告可用於評估需求、比較競爭對手、分析 GLP-1 療法的影響，並制定全球胃部器材市場的成長策略。

目錄

調查方法

• 步驟1：專案啟動與團隊組建
• 步驟2：準備資料系統並進行二次調查
• 步驟3：設計和準備訪談和調查問卷
• 步驟4：進行一次調查
• 步驟5：調查分析：建立基準估計值
• 步驟6：市場預測與分析
• 步驟7：辨識策略機會
• 步驟8：最終審核和市場投入
• 步驟9：客戶回饋與市場監測

全球關稅的影響

胃腸道器械市場

• 執行摘要
  • 全球胃腸道器械市場概覽
  • 競爭分析
  • 目標市場
  • 目標區域
• 介紹
  • 處於風險中的族群
• 市場概覽
  • 依細分市場
  • 依地區
• 市場分析與預測
  • 整體胃腸道器械市場
  • 胃束帶市場
  • 胃內球囊市場
• 促進因素和抑制因素
• 競爭性市場佔有率分析

附錄

Global Gastric Device Market Report to 2032

The global gastric device market was valued at over $124 million in 2025. It is expected to grow modestly at a compound annual growth rate (CAGR) of approximately 1.1%, reaching approximately $134 million by 2032.

This comprehensive report covers the global market for gastric devices, including gastric balloons and gastric bands. Gastric bands now represent a very small and declining portion of the market.

The analysis includes unit sales, average selling prices (ASPs), market size, growth trends, market drivers and limiters, market forecasts through 2032, and historical data back to 2022. It also includes recent mergers and acquisitions, company profiles, product portfolios and leading competitors.

Growth in this market is limited by strong competition from bariatric surgery and the rapid adoption of GLP-1 receptor agonist medications. Gastric devices are increasingly positioned as temporary, reversible or bridge therapies rather than definitive obesity treatments.

Market Overview

The global gastric device market includes devices used to support weight-loss interventions, primarily gastric balloons and gastric bands. These devices are designed to help patients lose weight through temporary gastric volume reduction or anatomical restriction.

Gastric balloons represent the more relevant segment of the market today. They are typically positioned as less invasive, temporary and reversible options for patients who are unwilling to undergo surgery or who may not qualify for more invasive bariatric procedures.

Gastric bands have declined significantly. Even adjustable band systems, including legacy LAP-BAND(R) platforms, have experienced sustained contraction due to long-term complication rates, revision procedures and shifting surgeon preference toward other bariatric techniques.

Since 2023, GLP-1 receptor agonist medications have materially impacted the gastric device market. In the U.S. in particular, balloon procedure volumes declined significantly in 2023 as pharmacologic weight-loss therapies gained mainstream adoption. While long-term adherence and durability remain under evaluation, their short-term effect on interventional weight-loss procedures has been substantial.

Market Drivers

Increasing obesity rates continue to support long-term demand for weight-loss interventions. Morbid obesity is commonly defined as a BMI over 40, or over 35 with obesity-related comorbidities such as type 2 diabetes or hypertension. This growing patient population sustains the broader bariatric treatment ecosystem.

However, the direct impact of obesity prevalence on gastric devices is limited. Gastric balloons and bands serve a more selective patient group than bariatric surgery or pharmacologic therapies. Demand is strongest among patients seeking non-surgical, temporary or reversible treatment options.

New developments and market repositioning are also shaping the gastric device market. As gastric banding and balloon procedures have declined over time, manufacturers have repositioned gastric devices as adjunctive or bridge therapies rather than permanent solutions. Product development is increasingly focused on less invasive systems that support selected patient needs while reducing procedural burden and anatomical alteration.

Market Limiters

Bariatric surgery remains the strongest limiter for the gastric device market. Procedures such as sleeve gastrectomy and gastric bypass offer more durable weight-loss outcomes and are supported by well-established clinical evidence. As a result, surgical approaches have become the preferred standard of care for many patients with severe obesity.

Robotic-assisted bariatric surgery further reinforces this shift. Robotic platforms improve surgeon ergonomics, visualization and precision in complex bariatric procedures. This strengthens the surgical value proposition and makes surgery more attractive in settings where hospitals have access to robotic platforms.

GLP-1 receptor agonist medications have also become a major limiter. Since 2023, these drugs have reduced demand for some interventional weight-loss procedures, especially gastric balloon procedures in the U.S. Even though long-term adherence, cost and durability are still being evaluated, their near-term impact has been strong enough to materially pressure the gastric device market.

Market Coverage and Data Scope

• Quantitative coverage: Market size, market shares, market forecasts, market growth rates, units sold and average selling prices.
• Qualitative coverage: Market drivers and limiters, market size and growth trends, recent mergers and acquisitions, company profiles, product portfolios and leading competitors.
• Time frame: Base year 2025, forecasts to 2032, and historical data back to 2022.
• Data types included: Unit sales, average selling prices, market size and growth trends, market drivers and limiters, market forecasts through 2032, historical data, recent mergers and acquisitions, company profiles and product portfolios.
• Method note: Market revenue is modeled using unit sales and average selling prices, with segmentation by device type used to assess demand across gastric bands and gastric balloons.

The report is designed to help readers evaluate how obesity prevalence, GLP-1 adoption, bariatric surgery, robotic-assisted procedures and product repositioning are shaping the global gastric device market.

Markets Covered and Segmentation

Gastric Device Market

• Device type: Gastric band and gastric balloon.

Gastric bands include adjustable banding systems used to restrict stomach capacity. This segment now represents a small and declining portion of the total gastric device market.

Gastric balloons include temporary, space-occupying devices intended to support short-term weight loss, often in combination with lifestyle intervention or broader obesity management programs.

Each segment is analyzed through relevant quantitative measures, including market size, market shares, market forecasts, market growth rates, units sold and average selling prices.

Competitive Analysis

Allurion Technologies is a key competitor in the global gastric balloon market. The company offers the Allurion(R) Balloon system, a swallowable, procedure-light weight-loss solution designed to avoid endoscopy for placement and removal. The platform is positioned as a minimally invasive and reversible alternative to both surgical bariatric procedures and traditional endoscopic balloons.

In February 2026, Allurion received U.S. FDA premarket approval for its gastric balloon system for short-term weight loss in combination with lifestyle intervention. This marked its formal entry into the U.S. market and significantly expanded the company's commercial footprint. This regulatory milestone strengthens Allurion's positioning within the North American gastric device segment.

Boston Scientific maintained a notable presence in the gastric device segment following the integration of Apollo Endosurgery into its portfolio. The company's position is supported by endoluminal and bariatric-adjacent technologies, including the OverStitch(TM) endoscopic suturing system, which complements its broader minimally invasive and gastrointestinal surgery franchise.

Medtimo, formerly ReShape Lifesciences, remained a niche competitor in 2025, primarily associated with the legacy LAP-BAND(R) adjustable gastric banding system. While the company continues to pursue additional obesity treatment technologies, including balloon-based solutions, these products had not yet materially contributed to market revenue as of 2025.

Technology and Practice Trends

Gastric balloons are increasingly positioned as temporary and reversible obesity treatment options. This positioning is important as the market shifts away from permanent or anatomy-altering devices.

Swallowable balloon systems are an important area of development. Products designed to reduce or avoid endoscopy may lower procedural burden and appeal to patients seeking less invasive treatment options.

Gastric bands continue to decline as clinical preference shifts toward sleeve gastrectomy, gastric bypass and other bariatric approaches. Long-term complication rates and revision procedures have reduced surgeon and patient interest in banding.

GLP-1 medications are reshaping the obesity treatment pathway. Their rapid adoption has created a new standard of comparison for non-surgical weight-loss interventions, placing pressure on gastric device manufacturers to prove value in patient groups where medication adherence, cost or eligibility may be challenging.

Robotic-assisted bariatric surgery is strengthening the appeal of surgical treatment. As surgical workflows become more precise and standardized, gastric devices face greater pressure from procedures that offer more durable outcomes.

Manufacturers are increasingly repositioning gastric devices as adjunctive or bridge therapies. This may include use in patients who are not ready for surgery, are not surgical candidates or require temporary weight reduction before a more definitive intervention.

Geography

This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.

Why This Report

How large is the global gastric device market, and how is it expected to grow through 2032?

How are gastric balloons and gastric bands performing across global obesity treatment markets?

How are unit sales, average selling prices and market values changing over time?

Why have gastric bands become a small and declining portion of the market?

How has GLP-1 medication adoption affected gastric balloon procedure volumes?

What role do gastric devices still play as temporary, reversible or bridge therapies?

How are bariatric surgery and robotic-assisted bariatric procedures limiting market growth?

Which companies are active in the gastric device market, and how are Allurion Technologies, Boston Scientific and Medtimo positioned?

The Global Gastric Device Market Report from iData Research answers these questions with detailed market sizing, ASP trends, forecasts and competitive share insights. Use it to evaluate demand, benchmark competitors, assess the impact of GLP-1 therapies and plan for growth across the global gastric device market.

TABLE OF CONTENT

Research Methodology

• Step 1: Project Initiation & Team Selection
• Step 2: Prepare Data Systems And Perform Secondary Research
• Step 3: Preparation For Interviews & Questionnaire Design
• Step 4: Performing Primary Research
• Step 5: Research Analysis: Establishing Baseline Estimates
• Step 6: Market Forecast And Analysis
• Step 7: Identify Strategic Opportunities
• Step 8: Final Review And Market Release
• Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

Gastric Device Market

• 14.1 Executive Summary
  • 14.1.1 Global Gastric Device Market Overview
  • 14.1.2 Competitive Analysis
  • 14.1.3 Markets Included
  • 14.1.4 Regions Included
• 14.2 Introduction
  • 14.2.1 Population At Risk
• 14.3 Market Overview
  • 14.3.1 By Segment
  • 14.3.2 By Region
• 14.4 Market Analysis And Forecast
  • 14.4.1 Total Gastric Device Market
  • 14.4.2 Gastric Band Market
  • 14.4.3 Gastric Balloon Market
• 14.5 Drivers And Limiters
  • 14.5.1 Market Drivers
  • 14.5.2 Market Limiters
• 14.6 Competitive Market Share Analysis

Appendix

LIST OF CHARTS

• Chart 14-1: Gastric Device Market, Global, 2025 & 2032
• Chart 14-2: Laparoscopic Procedures, Global, 2025
• Chart 14-3: Gastric Device Market by Segment, Global, 2022 - 2032
• Chart 14-4: Gastric Device Market by Region, Global, 2022 - 2032
• Chart 14-5: Leading Competitors, Gastric Device Market, Global, 2025

LIST OF FIGURES

• Figure 14-1: Gastric Devices Markets Covered
• Figure 14-2: Gastric Device Regions Covered, Global (1 of 2)
• Figure 14-3: Gastric Device Regions Covered, Global (2 of 2)
• Figure 14-4: Gastric Device Market by Segment, Global, 2022 - 2032 (US$M)
• Figure 14-5: Gastric Device Market by Region, Global, 2022 - 2032 (US$M)
• Figure 14-6: Total Gastric Device Market, Global, 2022 - 2032
• Figure 14-7: Units Sold by Region, Gastric Device Market, Global, 2022 - 2032
• Figure 14-8: Average Selling Price by Region, Gastric Device Market, Global, 2022 - 2032 (US$)
• Figure 14-9: Market Value by Region, Gastric Device Market, Global, 2022 - 2032 (US$M)
• Figure 14-10: Gastric Band Market, Global, 2022 - 2032
• Figure 14-11: Units Sold by Region, Gastric Band Market, Global, 2022 - 2032
• Figure 14-12: Average Selling Price by Region, Gastric Band Market, Global, 2022 - 2032 (US$)
• Figure 14-13: Market Value by Region, Gastric Band Market, Global, 2022 - 2032 (US$M)
• Figure 14-14: Gastric Balloon Market, Global, 2022 - 2032
• Figure 14-15: Units Sold by Region, Gastric Balloon Market, Global, 2022 - 2032
• Figure 14-16: Average Selling Price by Region, Gastric Balloon Market, Global, 2022 - 2032 (US$)
• Figure 14-17: Market Value by Region, Gastric Balloon Market, Global, 2022 - 2032 (US$M)
• Figure 14-18: Leading Competitors, Gastric Device Market, Global, 2025